NURS FPX 6030 Assessment 3 Intervention Plan Design
Intervention Plan Design
A comprehensive plan outlining the steps to implement an intervention to deal with a specific issue or problem is known as an intervention plan (Holopainen et al., 2020). The goals and objectives of the intervention, the target population, and the available resources will all impact how the intervention is designed. This intervention plan design is based on the PICOT question discussed in the previous assessments.
NURS FPX 6030 Assessment 3 Intervention Plan Design
It is essential to consider the following factors to design an intervention plan for this PICOT question. First, the goals and objectives of the intervention should be defined. The objective of this study is to examine the efficacy of cardiovascular therapy and pharmacological therapy in lowering blood sugar levels in patients with Type 2 Diabetes over the course of one month. The primary objective is to determine which intervention is more effective. The target population should be identified. In this circumstance, the audience is individuals with Type 2 Diabetes.
Intervention Plan Components
When creating an intervention plan for needs relating to the PICOT question, the following elements should be taken into account: promoting health, quality enhancement, protection, education, or management needs.
Establishing Clear Goals
Establishing clear goals and objectives is essential for a pharmacotherapy plan to manage Type 2 Diabetes. These may include reducing blood sugar levels to a specific target range, improving hemoglobin A1c levels, and reducing the risk of long-term complications associated with diabetes (Mardani et al., 2022).
The target population for a pharmacotherapy plan should be carefully considered to ensure that the intervention is appropriate and relevant for the targeted group. This may involve considering factors such as the severity of diabetes, the presence of comorbidities, and the individual’s preferences and lifestyle (Wake et al., 2021).
Intervention strategies for a pharmacotherapy plan may include using medications such as metformin, sulfonylureas, and thiazolidinediones to lower blood glucose levels and improve diabetes control. Other methods may include insulin therapy and lifestyle modifications, such as diet and exercise.
Intervention strategies for a lifestyle modification intervention therapy plan may include increasing physical activity and modifying diet to improve cardiovascular health. Other methods may include medication management, stress management techniques, and support from healthcare providers and other resources (Wake et al., 2021).
A detailed implementation plan is essential for the success of a pharmacotherapy plan for managing Type 2 Diabetes. This may involve coordinating with healthcare providers, pharmacies, and other resources to ensure that the individual has access to the necessary medications and support.
An evaluation plan should include measures to assess the effectiveness of the intervention and criteria to determine the plan’s success. Ongoing evaluation is essential to identify improvement areas and make necessary adjustments to the pharmacotherapy (Fernandez et al., 2019).
Criteria to Determine Success
To evaluate the success of the plan, the following criteria could be considered:
- Improvement in blood sugar control as measured by hemoglobin A1c levels
- Reduction in the number of hypoglycemic episodes
- Improvement in insulin sensitivity
- Reduction in the risk of complications related to Type 2 Diabetes, such as cardiovascular disease or kidney damage
- Patient satisfaction with the interventions
- Adherence to the interventions by the target population
- Cost-effectiveness of the interventions
Cultural Needs and Characteristics
The formulation of intervention plan components for the PICOT question can be significantly influenced by the cultural demands and features of the target population as well as the environment in which the intervention will be implemented. Understanding these factors can ensure that the intervention is relevant, appropriate, and effective for the target population (Escoffery et al., 2018).
If the target population has cultural beliefs that may affect their acceptance of specific interventions, it is essential to consider this when developing intervention strategies. Some cultural groups may have ideas about the role of health professionals or the use of certain medications that may influence their willingness to participate in the intervention. Additionally, if the setting in which the intervention will be implemented is unfamiliar or uncomfortable for the target population, this may affect their ability to engage with the intervention (Escoffery et al., 2018).
Cultural characteristics, such as language, can also be essential considerations in healthcare intervention planning. For example, language barriers can impact the effectiveness of an intervention by hindering communication between healthcare providers and patients. This can lead to misunderstandings and a need for more understanding of treatment recommendations or instructions, which can negatively impact the ability of patients to follow their treatment plan (Madula et al., 2018).
Assumptions of the Discussion
The assumptions upon which this explanation is based include the idea that cultural needs and characteristics, as well as the setting, can influence the acceptability and effectiveness of an intervention and that it is essential to consider these factors when developing an intervention plan.
Theoretical Nursing Models
When designing an intervention plan, it is essential to consider a range of theories, approaches, and technologies to identify the most effective and appropriate strategies for addressing the needs of the target population. In this context, it is helpful to consider the strengths and weaknesses of different options to make informed decisions about which interventions to include in the plan. The following are some examples of theories, approaches, and technologies that may be relevant to an intervention plan, along with their respective strengths and weaknesses:
Self-Care Deficit Theory
This theory suggests that individuals have a basic need for self-care and that a self-care deficit occurs when this need is not met. Strengths of this theory include its focus on the individual’s role in their health care and its emphasis on the importance of education in promoting self-care (Yuk, 2021).
Weaknesses of this Model
A weakness of this theory is that it may need to fully consider the impact of external factors, such as societal or cultural influences, on an individual’s ability to engage in self-care (Yuk, 2021).
This approach, commonly used in substance abuse treatment, involves helping individuals explore and resolve their ambivalence about changing their behavior. It can help address the complex behaviors and motivations related to diabetes management. Moreover, It can also help in better adherence to diabetes self-management interventions. Strengths of this approach include its focus on the individual’s autonomy and its potential to increase motivation for change (Berhe et al., 2020).
NURS FPX 6030 Assessment 3 Intervention Plan Design
A weakness of this approach is that it may not be effective for all individuals, as some may not be receptive to the idea of change or may need more skills or resources to make changes.
This technology involves the use of electronic communication to provide healthcare services remotely. Strengths of telemedicine include its potential to increase access to care for individuals in underserved or remote areas and its ability to reduce the need for in-person visits (Pradeepa et al., 2019).
A concern for telemedicine is that it may only be feasible for some individuals, as it may require access to specific technologies.
Evidence for Major Components of Intervention
Regarding managing Type 2 Diabetes, pharmacotherapy, and lifestyle modification are two commonly used interventions. Pharmacotherapy is the use of drugs to reduce blood glucose levels and enhance diabetes management. Similar to diet and exercise, lifestyle modification entails altering a person’s way of life to enhance cardiovascular health and blood sugar regulation. Both these interventions are effective in improving the health of individuals with Type 2 Diabetes, but they also have their limitations and risks.
The effectiveness of pharmacotherapy as a component of an intervention plan for managing Type 2 Diabetes is supported by a wealth of evidence from the literature and best practices (Catapan et al., 2021). This type of therapy involves using medications to lower blood glucose levels and improve diabetes control and is effective in enhancing hemoglobin A1c levels in patients with Type 2 Diabetes (Concepción Zavaleta et al., 2021). However, it is essential to consider pharmacotherapy’s potential limitations and risks. Some blood glucose-lowering drugs may cause gastrointestinal distress or a higher risk of hypoglycemia as a side effect. Additionally, consistent use of these drugs may raise the chance of acquiring specific health problems including renal damage or cardiovascular disease (Concepción Zavaleta et al., 2021). Therefore, it is essential to weigh pharmacotherapy’s potential benefits and risks and consider other interventions, such as lifestyle modification, as needed.
Lifestyle modification interventions are also a vital component of an intervention plan for managing Type 2 Diabetes. To enhance cardiovascular health and sugar level control, this therapy entails a person modifying their lifestyle. For example, increasing physical activity and modifying diet can improve blood pressure and cholesterol levels, reduce the risk of cardiovascular disease, and improve overall cardiovascular health (Dahm et al., 2021). In addition, stress management techniques and support from healthcare providers and other resources can help individuals to maintain a healthy lifestyle and make lasting changes to their behavior (Berhe et al., 2020).
However, it is essential to consider that lifestyle modification interventions may only be feasible or appropriate for some individuals. Some may have physical limitations or need access to resources and support, making lifestyle changes challenging. Therefore, it is essential to consider the individual’s needs and preferences and to tailor the intervention to their specific circumstances.
Health Care Policy, Regulations, and Governing Bodies’ Effects on Stakeholder Needs
Evaluating how the intervention strategy for Type 2 Diabetes management is affected by stakeholder needs, health care policy, rules, and regulating bodies is essential. It is possible to design an intervention that is relevant, appropriate, and effective for the target population and setting. This can increase the likelihood of success and improve the overall impact of the intervention on blood sugar control. The needs and preferences of stakeholders, such as patients, caregivers, and healthcare providers, should be considered when developing the goals and objectives of the intervention. Healthcare policy and regulations may also impact the goals and objectives of the intervention, as well as the intervention strategies and implementation plan (Escoffery et al., 2018).
Access to care is a critical policy issue that must be addressed. In the United States, for example, the Affordable Care Act requires insurance plans to cover certain diabetes-related preventive services, such as blood pressure and cholesterol screenings and medications used to treat diabetes (Lee et al., 2019). This can be advantageous for people with Type 2 Diabetes because it ensures they can access the medications and other resources required to manage their condition (Lee et al., 2019).
However, some people may still face access barriers, such as high out-of-pocket costs or difficulty finding a provider who accepts their insurance. Governing bodies, such as professional associations or accrediting organizations, may also have guidelines or standards to consider when developing the intervention plan. For example, if the intervention involves using electronic medical records, it may be necessary to ensure that the system meets the relevant privacy and security standards (Mathews et al., 2019).
Assumptions of the Analysis
When designing an intervention plan for managing Type 2 Diabetes, it is essential to consider the potential impact of stakeholder needs, health care policy, regulations, and governing bodies on the plan. These external factors can significantly influence the development and implementation of the intervention and can impact its relevance, appropriateness, and effectiveness for the target population and setting. By analyzing these factors and taking them into account during the planning process, it is possible to design an intervention that is well-aligned with these considerations and has a higher likelihood of success in improving blood sugar control. This assumes that the review of stakeholder needs, health care policy, regulations, and governing bodies are necessary to ensure the effectiveness of the intervention plan (Wake et al., 2021).
Relevant Ethical and Legal Issues
In designing an ethical and legally sound intervention plan for managing Type 2 Diabetes, it is essential to consider relevant ethical and legal issues. Ethical considerations may include informed consent, confidentiality, beneficence, non-maleficence, and autonomy. These are the basic principles of medical ethics (Jorqui-Azofra, 2020). These issues are essential to ensure that the rights and freedom of individuals are respected. Moreover, it is necessary to consider that the interventions are designed to promote the overall well-being of the target population (Jorqui-Azofra, 2020).
Legal considerations may include regulatory requirements, liability, and privacy issues. It is essential to ensure that the intervention plan complies with relevant laws and regulations, as failure may result in legal consequences. Additionally, it is necessary to consider potential liability issues and to take steps to minimize risk. This may include establishing protocols for reporting adverse events or incidents, obtaining informed consent, and ensuring the confidentiality of sensitive information (Mercieca-Bebber et al., 2018).
In analyzing these issues, it is essential to identify unanswered questions or areas of uncertainty that may impact the analysis of the intervention plan. Some of these may include:
- Conflicting evidence or perspectives on specific issues
- Unknown or missing information that could improve the analysis
- Potential Impact of external factors on the intervention plan
- Availability of resources to support the implementation of the intervention plan
- Unanswered questions or areas of uncertainty may impact the analysis of the intervention plan (Moore et al., 2021).
By identifying and addressing this missing information, it is possible to improve the analysis and development of the intervention plan and to ensure that the project is informed by the most relevant and current evidence and considerations. This can increase the likelihood of success and improve the overall impact of the intervention on blood sugar control.
In conclusion, the effectiveness of drug therapy and lifestyle modification interventions for controlling blood sugar levels in patients with Type 2 Diabetes can be evaluated using a randomized controlled trial. While pharmacotherapy may rapidly impact blood glucose levels, it may also have potential side effects and long-term risks. In designing an intervention plan for the management of Type 2 Diabetes, it is essential to consider the major components of the program, including well-defined goals and objectives, the needs and characteristics of the target population, evidence-based intervention strategies, a detailed implementation plan, and an evaluation plan to assess the effectiveness of the intervention. It is also essential to consider the impact of cultural needs and characteristics, as well as the setting, on the development of the intervention plan.
NURS FPX 6030 Assessment 3 Intervention Plan Design
Berhe, K. K., Gebru, H. B., & Kahsay, H. B. (2020). Effect of motivational interviewing intervention on HgbA1C and depression in people with Type 2 Diabetes Mellitus (systematic review and meta-analysis). PLOS ONE, 15(10). https://doi.org/10.1371/journal.pone.0240839
Catapan, S. de C., Nair, U., Gray, L., Calvo, M., Bird, D., Janda, M., Fatehi, F., Menon, A., & Russell, A. (2021). Same goals, different challenges: A systematic review of perspectives of people with diabetes and healthcare professionals on Type 2 Diabetes care. Diabetic Medicine, 38(9). https://doi.org/10.1111/dme.14625
Concepción Zavaleta, M. J., Gonzáles Yovera, J. G., Moreno Marreros, D. M., Rafael Robles, L. del P., Palomino Taype, K. R., Soto Gálvez, K. N., Arriola Torres, L. F., Coronado Arroyo, J. C., & Concepción Urteaga, L. A. (2021). Diabetic gastro enteropathy: An underdiagnosed complication. World Journal of Diabetes, 12(6), 794–809. https://doi.org/10.4239/wjd.v12.i6.794
Dahm, P., MacDonald, R., McKenzie, L., Jung, J. H., Greer, N., & Wilt, T. (2021). Newer minimally invasive treatment modalities to treat lower urinary tract symptoms attributed to Benign Prostatic Hyperplasia. European Urology Open Science, 26, 72–82. https://doi.org/10.1016/j.euros.2021.02.001
Escoffery, C., Lebow-Skelley, E., Haardoerfer, R., Boing, E., Udelson, H., Wood, R., Hartman, M., Fernandez, M. E., & Mullen, P. D. (2018). A systematic review of adaptations of evidence-based public health interventions globally. Implementation Science, 13(1). https://doi.org/10.1186/s13012-018-0815-9
Fernandez, M. E., Ruiter, R. A. C., Markham, C. M., & Kok, G. (2019). Intervention mapping: Theory- and evidence-based health promotion program planning perspective and examples. Frontiers in Public Health, 7(209). https://doi.org/10.3389/fpubh.2019.00209
Holopainen, R., Simpson, P., Piirainen, A., Karppinen, J., Schütze, R., Smith, A., O’Sullivan, P., & Kent, P. (2020). Physiotherapists’ perceptions of learning and implementing a biopsychosocial intervention to treat musculoskeletal pain conditions: A systematic revmeta-synthesis of qualitative studies. Pain, 161(6), 1150–1168. https://doi.org/10.1097/j.pain.0000000000001809
Jorqui-Azofra, M. (2020). Regulation of clinical xenotransplantation: A reappraisal of the legal, ethical, and social aspects involved. Xenotransplantation, 315–358. https://doi.org/10.1007/978-1-0716-0255-3_20
Lee, J., Callaghan, T., Ory, M., Zhao, H., & Bolin, J. N. (2019). The impact of Medicaid expansion on diabetes management. Diabetes Care, 43(5). https://doi.org/10.2337/dc19-1173
Madula, P., Kalembo, F. W., Yu, H., & Kaminga, A. C. (2018). Healthcare provider-patient communication: A qualitative study of women’s perceptions during childbirth. Reproductive Health, 15(1). https://doi.org/10.1186/s12978-018-0580-x
Mardani, A., Paal, P., Weck, C., Jamshed, S., & Vaismoradi, M. (2022). Practical considerations of PRN medicines management: An integrative systematic review. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.759998
Mathews, S. C., McShea, M. J., Hanley, C. L., Ravitz, A., Labrique, A. B., & Cohen, A. B. (2019). Digital health: A path to validation. Npj Digital Medicine, 2(1). https://doi.org/10.1038/s41746-019-0111-3
Mercieca-Bebber, R., King, M. T., Calvert, M. J., Stockler, M. R., & Friedlander, M. (2018). The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient-Related Outcome Measures, Volume 9, 353–367. https://doi.org/10.2147/prom.s156279
Moore, G., Campbell, M., Copeland, L., Craig, P., Movsisyan, A., Hoddinott, P., Littlecott, H., O’Cathain, A., Pfadenhauer, L., Rehfuess, E., Segrott, J., Hawe, P., Kee, F., Couturiaux, D., Hallingberg, B., & Evans, R. (2021). Adapting interventions to new contexts—the ADAPT guidance. BMJ, n1679. https://doi.org/10.1136/bmj.n1679
Pradeepa, R., Rajalakshmi, R., & Mohan, V. (2019). Use of telemedicine technologies in diabetes prevention and control in resource-constrained settings: Lessons learned from emerging economies. Diabetes Technology & Therapeutics, 21(S2), S29–S216. https://doi.org/10.1089/dia.2019.0038
Wake, D. T., Smith, D. M., Kazi, S., & Dunnenberger, H. M. (2021). Pharmacogenomic clinical decision support: A review, how‐to guide, and future vision. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.2387
Yuk, J. (2021). Theory-based advanced nursing practice: A practice update on the application of Orem’s Self-Care Deficit Nursing Theory. SAGE Open Nursing. https://journals.sagepub.com/doi/full/10.1177/23779608211011993